Henry Schein, Inc. (LON:0L3C)
London · Delayed Price · Currency is GBP · Price in USD 63.60
+0.03 (0.05%)
At close: Oct 28, 2025
Henry Schein Market Cap
Henry Schein has a market cap or net worth of 5.77 billion as of October 29, 2025. Its market cap has decreased by -15.56% in one year.
Market Cap
5.77B
Enterprise Value
9.28B
Revenue
9.31B
Ranking
n/a
PE Ratio
20.34
Stock Price
63.60
Market Cap Chart
Since November 3, 1995, Henry Schein's market cap has increased from 263.64M to 5.77B, an increase of 2,088.83%. That is a compound annual growth rate of 10.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 5.77B | -16.27% |
| Dec 31, 2024 | 6.89B | -10.77% |
| Dec 29, 2023 | 7.72B | -14.04% |
| Dec 30, 2022 | 8.99B | 13.16% |
| Dec 31, 2021 | 7.94B | 13.56% |
| Dec 31, 2020 | 6.99B | -5.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 65.14B |
| Haleon | 31.21B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.97B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.69B |